MISSISSAUGA, Ontario, Sept. 2, 2011 /PRNewswire/ — Valeant
Pharmaceuticals International, Inc. (NYSE:
VRX) (TSX: VRX) today announced that certain members of its
senior management team will be participating at the following
J. Michael Pearson, Chairman and Chief Executive Officer will
make a presentation at the Bank of America Merrill Lynch Global
Healthcare Conference 2011 in London on Thursday, September 15,
2011 at 10:35 a.m. BT (5:35 a.m. ET).
Rajiv De Silva, President, Valeant Pharmaceuticals
International, Inc. and Chief Operating Officer, Specialty
Pharmaceuticals will make a presentation at the UBS Global Life
Sciences Conference in New York on Monday, September 19, 2011 at
8:30 a.m. ET.
Live webcasts and audio archives of the presentations will be
available on the company’s Web site at www.valeant.com.
Click on Investor Relations, and then the link to Events and
Presentations. Participants should allow approximately five to ten
minutes prior to the presentation’s start time to visit the site
and download any streaming media software needed to listen to the
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of neurology, dermatology and branded
generics. More information about Valeant can be found at www.valeant.com.
Laurie W. Little